447 related articles for article (PubMed ID: 16421600)
21. A retroviral packaging cell line for pseudotype vectors based on glioma-infiltrating progenitor cells.
Fischer YH; Miletic H; Giroglou T; Litwak S; Stenzel W; Neumann H; von Laer D
J Gene Med; 2007 May; 9(5):335-44. PubMed ID: 17474071
[TBL] [Abstract][Full Text] [Related]
22. A novel system for the production of fully deleted adenovirus vectors that does not require helper adenovirus.
Cheshenko N; Krougliak N; Eisensmith RC; Krougliak VA
Gene Ther; 2001 Jun; 8(11):846-54. PubMed ID: 11423932
[TBL] [Abstract][Full Text] [Related]
23. Generation of a flexible cell line with regulatable, high-level expression of HIV Gag/Pol particles capable of packaging HIV-derived vectors.
Sparacio S; Pfeiffer T; Schaal H; Bosch V
Mol Ther; 2001 Apr; 3(4):602-12. PubMed ID: 11319923
[TBL] [Abstract][Full Text] [Related]
24. Construction and production of oncotropic vectors, derived from MVM(p), that share reduced sequence homology with helper plasmids.
Clément N; Velu T; Brandenburger A
Cancer Gene Ther; 2002 Sep; 9(9):762-70. PubMed ID: 12189526
[TBL] [Abstract][Full Text] [Related]
25. Safe and efficient ecotropic and amphotropic packaging lines for use in gene transfer experiments.
Markowitz DG; Goff SP; Bank A
Trans Assoc Am Physicians; 1988; 101():212-8. PubMed ID: 3077729
[TBL] [Abstract][Full Text] [Related]
26. A novel herpesvirus amplicon system for in vivo gene delivery.
Wang S; Di S; Young WB; Jacobson C; Link CJ
Gene Ther; 1997 Nov; 4(11):1132-41. PubMed ID: 9425435
[TBL] [Abstract][Full Text] [Related]
27. Comparison of HIV-1 and EIAV-based lentiviral vectors in corneal transduction.
Beutelspacher SC; Ardjomand N; Tan PH; Patton GS; Larkin DF; George AJ; McClure MO
Exp Eye Res; 2005 Jun; 80(6):787-94. PubMed ID: 15939034
[TBL] [Abstract][Full Text] [Related]
28. [Stable cell line for secretion of replication-defective hepatitis B virus vector expressing blasticidin resistant gene].
Liu JX; Sun DX; Cao ZC
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Aug; 23(4):316-8. PubMed ID: 20108785
[TBL] [Abstract][Full Text] [Related]
29. Transmission of endogenous VL30 retrotransposons by helper cells used in gene therapy.
Chakraborty AK; Zink MA; Hodgson CP
Cancer Gene Ther; 1994 Jun; 1(2):113-8. PubMed ID: 7621242
[TBL] [Abstract][Full Text] [Related]
30. A surface-modified baculovirus vector with improved gene delivery to B-lymphocytic cells.
Ge J; Huang Y; Hu X; Zhong J
J Biotechnol; 2007 May; 129(3):367-72. PubMed ID: 17374412
[TBL] [Abstract][Full Text] [Related]
31. MuLV packaging systems as models for estimating/measuring retrovirus recombination frequency.
Patience C; Takeuch Y; Cosset FL; Weiss RA
Dev Biol (Basel); 2001; 106():169-79; discussion 253-63. PubMed ID: 11761229
[TBL] [Abstract][Full Text] [Related]
32. Generation of replication-defective helper-free vectors based on simian immunodeficiency virus.
Kim SS; Kothari N; You XJ; Robinson WE; Schnell T; Uberla K; Fan H
Virology; 2001 Mar; 282(1):154-67. PubMed ID: 11259198
[TBL] [Abstract][Full Text] [Related]
33. Overcoming promoter competition in packaging cells improves production of self-inactivating retroviral vectors.
Schambach A; Mueller D; Galla M; Verstegen MM; Wagemaker G; Loew R; Baum C; Bohne J
Gene Ther; 2006 Nov; 13(21):1524-33. PubMed ID: 16763662
[TBL] [Abstract][Full Text] [Related]
34. Development of recombinant adeno-associated virus vectors carrying small interfering RNA (shHec1)-mediated depletion of kinetochore Hec1 protein in tumor cells.
Li L; Yang L; Scudiero DA; Miller SA; Yu ZX; Stukenberg PT; Shoemaker RH; Kotin RM
Gene Ther; 2007 May; 14(10):814-27. PubMed ID: 17330085
[TBL] [Abstract][Full Text] [Related]
35. Novel recombinant adenovirus type 41 vector and its biological properties.
Lu ZZ; Zou XH; Dong LX; Qu JG; Song JD; Wang M; Guo L; Hung T
J Gene Med; 2009 Feb; 11(2):128-38. PubMed ID: 19097028
[TBL] [Abstract][Full Text] [Related]
36. A novel packaging system for the generation of helper-free oncolytic MVM vector stocks.
Brandenburger A; Russell S
Gene Ther; 1996 Oct; 3(10):927-31. PubMed ID: 8908507
[TBL] [Abstract][Full Text] [Related]
37. Modest increases in the titers of helper virus-free herpes simplex virus 1 (HSV-1) vectors by packaging in a cell line with inducible expression of HSV-1 VP16 or by treatment with N,N'-hexamethylene-bis-acetamide.
Sun M; Lee J; Yu L; Geller AI
Acta Virol; 2000 Dec; 44(6):365-9. PubMed ID: 11332280
[TBL] [Abstract][Full Text] [Related]
38. A modular set of helper-dependent herpes simplex virus expression vectors.
Strathdee CA; McLeod MR
Mol Ther; 2000 May; 1(5 Pt 1):479-85. PubMed ID: 10933969
[TBL] [Abstract][Full Text] [Related]
39. [Development of hygromycin-resistant packaging cell line for hepatitis B virus-derived vectors].
Hu DR; Sun DX; Xiong JH; Wu GH; Hu XL; Li J; Fan GR; Han JQ
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2004 Mar; 18(1):28-30. PubMed ID: 15340521
[TBL] [Abstract][Full Text] [Related]
40. Long-term episomal gene delivery in human lymphoid cells using human and avian adenoviral-assisted transfection.
Kelleher ZT; Vos JM
Biotechniques; 1994 Dec; 17(6):1110-7. PubMed ID: 7873181
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
